Charles Kim,
MBA, named Chief Operating Officer and Chief Financial
Officer
Susanna Ling
named Senior Vice President of Industry Programs, Sponsorships and
Partnerships
NEW YORK, June 20, 2024 /PRNewswire/ -- Cure.®,
a healthcare innovation campus in New
York City, today announced Charles
Kim, MBA, as its new Chief Operating Officer (COO) and Chief
Financial Officer (CFO), and Susanna
Ling as its new Senior Vice President of Industry Programs,
Sponsorships, and Partnerships. Kim and Ling report to Chief
Executive Officer Seema Kumar in
these newly created senior leadership roles.
Kim joins Cure with a strong track record of successfully
scaling startups and driving and optimizing organic and inorganic
top-line growth. Ling brings to Cure expertise in managing
international biotechnology, pharmaceutical, and non-profit
partnerships and sponsorships, including developing, managing and
marketing campaigns, initiatives and programming.
"I am delighted to add Charles' operations and financial
experience, as well as Susanna's expertise in forging strong
alliances, to Cure," said Cure CEO Seema
Kumar. They will help drive Cure's continued growth to
be the nexus of healthcare innovation and go-to destination for
healthcare entrepreneurs. Both Charles and Susanna are
exceptionally qualified to advance Cure's existing and forthcoming
efforts, helping us build an ecosystem of healthcare
entrepreneurial excellence."
Kim previously served as COO of Full Circle Brands, Executive
Vice President and Co-COO of Ascend Wellness Holdings and Vice
President of Distribution and Logistics of Freshly (Nestle). Kim
earned a bachelor's degree in political science and economics from
the University of Chicago and an MBA
from the Kellogg School of Management at Northwestern University.
"I'm excited to join Cure and leverage my financial and
operational skills and expertise to help drive profitable growth
and operational excellence, all while furthering its mission of
advancing health," said Kim.
Ling previously served as Vice President of Industry
Partnerships and Sponsorship at the Biotechnology Innovation
Organization (BIO), Vice President of Business and Program
Development at the EBD Group/Informa, and on management teams at
the Milken Institute/Faster Cures, Guildford Pharmaceuticals,
MedImmune and the National Cancer Institute. Ling earned a
bachelor's degree in biology from Rutgers
University.
"I'm thrilled to expand Cure's partnerships, expand our digital
ecosystem, and create new programming to complement our Tuesday
Talks series, Xchange Challenge, XSeed Award, workshops and other
initiatives. By leveraging Cure's shared mission with the life
sciences, patient advocacy and investment communities, we aim to
advance areas like women's health, biotech entrepreneurship, rare
diseases, cell/gene therapy and more, ultimately benefiting
patients," said Ling.
About Cure.
Cure is a vibrant healthcare innovation
campus in the heart of New York
City with a mission to advance health. Supporting healthcare
and life science entrepreneurs, Cure offers digital and in-person
content, programming, and learnings on critical health and business
topics. The campus at 345 Park Avenue South features laboratory and
business facilities, office space and premium event venues,
including an education center, conference center, and iconic
rooftop terrace. Residents and members collaborate across the
spectrum of healthcare and focus on diagnostic, device, drug
development and production as well as care delivery and public
health. For more information, please visit wewillcure.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cure-adds-chief-operating-financial-officer-and-svp-industry-programs-and-sponsorships-to-senior-leadership-team-302178156.html
SOURCE Cure